Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
26 May 2023 - 9:05PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934
For the Month of May 2023
Commission File Number: 001-37710
HUTCHMED (CHINA) LIMITED
(Translation of registrant’s name into English)
48th Floor, Cheung Kong Center, 2 Queen’s Road Central, Hong Kong
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ⌧ Form 40-F ◻
HUTCHMED (CHINA) LIMITED
Form 6-K
EXHIBIT INDEX
| | |
Exhibit No. | | Description |
| | |
Exhibit 99.1 | | Press release relating to presentations at the 2023 ASCO Annual Meeting |
Exhibit 99.2 | | Press release relating to new drug application (NDA) for fruquintinib for treatment of previously treated metastatic colorectal cancer granted priority review |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| HUTCHMED (CHINA) LIMITED |
| | |
| | |
| By: | /s/ Johnny Cheng |
| Name: | Johnny Cheng |
| Title: | Chief Financial Officer |
Date: May 26, 2023
HUTCHMED China (NASDAQ:HCM)
Historical Stock Chart
From Mar 2024 to Apr 2024
HUTCHMED China (NASDAQ:HCM)
Historical Stock Chart
From Apr 2023 to Apr 2024
